Policy & Regulation
Sherlock Biosciences Forges Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2
12 August 2020 - - US-based engineering biology company Sherlock Biosciences has forged a research collaboration with Dartmouth-Hitchcock Health to launch a clinical study of the Sherlock CRISPR SARS-...
GeneCentric Therapeutics Enters into Research Collaboration with Janssen on Genomic Drug Response Biomarkers for Non-Muscle Invasive Bladder Cancer
12 August 2020 - - US-based RNA-based genomic solutions provider GeneCentric Therapeutics has entered into a research collaboration with Janssen Research and Development, LLC (Janssen) around RNA-base...
Chrysalis BioTherapeutics Receives Additional Funding from the National Institutes of Health for COVID-19 Therapeutic Development
12 August 2020 - - US-based biotechnology company Chrysalis BioTherapeutics, Inc., which is developing regenerative drugs that target vascular endothelial and progenitor cells,

The Natio...
Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia
12 August 2020 - - The Phase 2 clinical study of US-based Blade Therapeutics' investigational therapeutic, BLD-2660, has enrolled half of the anticipated 120 coronavirus disease-19 (COVID-19) pne...
India Globalization Capital wins FDA approval to begin Phase 1 human trial study of investigational cannabinoid formulation in patients with Alzheimer's disease
12 August 2020 - Life science company India Globalization Capital (NYSE American:IGC) reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) to launch a Phase 1 hum...
Romark begins new Phase 3 clinical trial of NT-300 for the treatment of COVID-19
12 August 2020 - Pharmaceutical company Romark disclosed on Tuesday the start of a Phase 3 clinical trial of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets) for t...
Related Headlines

Romark starts phase three clinical trial of COVID-19 drug NT-300

Brazilian state of Paraná to sign agreement with Russia for testing COVID-19 vaccine

US government signs USD1.525bn deal with Moderna for 100 million doses of its COVID-19 vaccine

Russia's head of COVID-19 vaccine research states he has administered the vaccine to himself and his family

Gilead Submits New Drug Application to US Food and Drug Administration for Veklury for the Treatment of COVID-19

XPRIZE Pandemic Alliance, New England Complex Systems Institute Forge COVID-19 CT Scan Collaborative

The New England Journal of Medicine Publishes Non-Human Primate Preclinical Viral Challenge Study of an mRNA Vaccine Against COVID-19

Moderna, AstraZeneca-Oxford Lead the Race for a COVID-19 Vaccine, but Public Availability Will Take Nearly a Year, and Return to Normalcy Even Longer, Say US Physicians in InCrowd Data

IAVI and Wellcome Issue a Global Call to Action: Monoclonal Antibodies for COVID-19 and Other Diseases Could Save Millions of Lives

Russia's "Sputnik V" COVID-19 vaccine in demand by 20 countries

Penn State Microbiome Center and GALT Enter Collaboration to Advance Research

Dicerna Touts Positive Clinical Data for Investigational Treatments RG6346 for Chronic Hepatitis B Virus and Nedosiran for Primary Hyperoxaluria

Daiichi Sankyo Forges Clinical Trial Collaboration with AstraZeneca to Evaluate Patritumab Deruxtecan in Combination with TAGRISSO in EGFR-Mutated Non-Small Cell Lung Cancer

Asclepius Meditec's hydrogen oxygen generator AMS-H-03 helps improve COVID-19 disease severity and dyspnea

Tevogen Bio partners with Dr Neal Flomenberg to investigate proprietary T-Cell therapy for the treatment of COVID-19 and influenza